Athanor Capital, LP Syndax Pharmaceuticals Inc Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $416,852 - $531,660	-21,621 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $49,226 - $86,194	3,260 Added 17.76%	21,621 $481,000
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $47,922 - $62,560	-3,579 Reduced 16.31%	18,361 $271,000
Q2 2020 Aug 13, 2020	BUY	$8.94 - $20.98 $196,143 - $460,301	21,940 New	21,940 $325,000
Q3 2019 Nov 14, 2019	SELL	$7.47 - $10.76 $83,664 - $120,512	-11,200 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$4.9 - $9.31 $54,880 - $104,272	11,200 New	11,200 $104,000

232

96.9M

1.39M

543K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $927M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.